Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders

Schizophrenia Bulletin
Robert E DrakeBarbara S Helmstetter

Abstract

The long-term courses of people with schizophrenia and of those with substance use disorder have been studied separately and extensively. The long-term course of clients with co-occurring schizophrenic and substance use disorders has, however, not been examined. This article reports 10-year outcomes for 130 clients with co-occurring schizophrenic and substance use disorders in the New Hampshire Dual Diagnosis Study. In addition, we report on 6 "recovery outcomes," identified by dual diagnosis clients, as examples of positive coping behaviors. Longitudinal data were modeled using generalized estimating equation (GEE) methods. Participants improved steadily over 10 years in the outcome domains of symptoms, substance abuse, institutionalization, functional status, and quality of life. Further, at the 10-year follow-up, substantial proportions were above cutoffs selected by dual diagnosis clients as indicators of recovery: 62.7% were controlling symptoms of schizophrenia; 62.5% were actively attaining remissions from substance abuse; 56.8% were in independent living situations; 41.4% were competitively employed; 48.9% had regular social contacts with non-substance abusers; and 58.3% expressed overall life satisfaction. These 6 outc...Continue Reading

References

Oct 1, 1991·The American Psychologist·K M Abram, L A Teplin
Jan 11, 1990·Schizophrenia Bulletin·M B BowersP I Jatlow
Nov 21, 1990·JAMA : the Journal of the American Medical Association·D A RegierF K Goodwin
Jan 1, 1990·Schizophrenia Bulletin·K T MueserK G Yadalam
Jan 1, 1990·Schizophrenia Bulletin·R E DrakeM S Beaudett
Oct 1, 1972·Journal of Consulting and Clinical Psychology·L Gurel, T W Lorei
Jan 1, 1980·The Journal of Nervous and Mental Disease·A T McLellanC P O'Brien
May 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·P J DukeT R Barnes
Feb 1, 1994·American Journal of Public Health·C L CatonB Dominguez
Dec 1, 1995·The Journal of Nervous and Mental Disease·G J McHugoT H Ackerson
Jan 1, 1996·The American Journal of Orthopsychiatry·R E DrakeM A Wallach
May 1, 1996·Schizophrenia Research·C D SwoffordL B Inderbitzin
May 20, 1998·The American Journal of Orthopsychiatry·G B TeagueR E Drake
Feb 24, 2001·American Journal of Public Health·S D RosenbergM P Salyers
Mar 29, 2001·Psychiatric Services : a Journal of the American Psychiatric Association·R E DrakeL Rickards
Jan 5, 2002·Journal of Traumatic Stress·L A GoodmanUNKNOWN 5 Site Health and Risk Study Research Committee
Nov 16, 2002·Psychiatric Rehabilitation Journal·Helene L ProvencherKim T Mueser
Mar 3, 2004·The American Journal of Psychiatry·Delbert G RobinsonRobert M Bilder
May 7, 2004·Psychiatric Services : a Journal of the American Psychiatric Association·Sandra G ResnickAnthony F Lehman
Jun 30, 2004·Psychiatric Rehabilitation Journal·Robert E DrakeGregory J McHugo

❮ Previous
Next ❯

Citations

Apr 2, 2009·The Journal of Behavioral Health Services & Research·Lawrence D RickardsRobyn S Raysor
Sep 11, 2012·Journal of Dual Diagnosis·Benjamin F HenwoodEmmy Tiderington
Jul 20, 2006·Schizophrenia Bulletin·Gregory J McHugoAlan I Green
May 15, 2009·The Journal of Nervous and Mental Disease·Kelly A AschbrennerMarsha M Seltzer
Oct 26, 2006·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Scott Kellogg, Mary Jeanne Kreek
Jan 1, 2011·Journal of Dual Diagnosis·Kim T MueserRobert E Drake
Jun 5, 2015·Contemporary Nurse·Sini JacobBeverley Joan Taylor
Nov 14, 2014·Journal of Dual Diagnosis·Alison LucianoRobert E Drake
Jul 10, 2012·Comprehensive Psychiatry·Gregory P StraussDaniel N Allen
Apr 23, 2013·Comprehensive Psychiatry·Syarifah Hafizah Wan KasimSrijit Das
Jul 15, 2015·Psychological Science in the Public Interest : a Journal of the American Psychological Society·Patrick W CorriganDeborah A Perlick
May 2, 2017·Journal of Evidence-informed Social Work·Jennifer HarrisonAmy Curtis
Apr 7, 2009·Addictive Behaviors·David J Kavanagh, Jennifer M Connolly
Jan 1, 2010·Journal of the American Psychiatric Nurses Association·Paul H LysakerKelly D Buck
May 18, 2007·The Australian and New Zealand Journal of Psychiatry·Adrian C BradleyTerry J Lewin
Dec 9, 2017·International Journal of Mental Health Nursing·Chris WagstaffLloyd Tatham
Jun 26, 2007·Community Mental Health Journal·Gary R Bond, Robert E Drake
Jun 4, 2008·Current Opinion in Psychiatry·Gary R Bond, Robert E Drake
Aug 1, 2008·International Journal of Mental Health Nursing·Ian Munro, Karen-Leigh Edward
Apr 2, 2009·International Journal of Nursing Practice·Karen-Leigh Edward, Ian Munro
Nov 9, 2010·International Journal of Mental Health Nursing·Kate Irving, Richard Lakeman
Mar 19, 2008·Expert Review of Neurotherapeutics·Amine BenyaminaMichael Lukasiewcz
Aug 16, 2014·Administration and Policy in Mental Health·Marie-Josée FleuryJean Caron
Oct 5, 2013·The Cochrane Database of Systematic Reviews·Glenn E HuntMichelle Cleary
Dec 13, 2019·The Cochrane Database of Systematic Reviews·Glenn E HuntMichelle Cleary
May 17, 2011·European Psychiatry : the Journal of the Association of European Psychiatrists·D SchoepfR Heun
Mar 2, 2018·International Journal of Mental Health and Addiction·E BrekkeS Biong
Oct 8, 2019·Journal of the American Psychiatric Nurses Association·Lydia Ould BrahimCatherine Pugnaire Gros
Feb 14, 2013·The Journal of Behavioral Health Services & Research·Benjamin F HenwoodEmmy Tiderington
Sep 16, 2020·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Robert E DrakeGregory J McHugo
Jul 30, 2019·Frontiers in Psychiatry·Melissa A WeibellWenche Ten Velden Hegelstad
Apr 13, 2010·Journal of Mental Health·Richard Lakeman
Jun 30, 2012·Early Intervention in Psychiatry·Ross M G NormanRahul Manchanda
May 29, 2016·Community Mental Health Journal·Jennifer HarrisonJessaca Spybrook
Nov 30, 2018·The Psychiatric Quarterly·Mary V Seeman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.